Your email has been successfully added to our mailing list.

×
0 0 0 0 -0.00558312655086848 -0.0124069478908189 -0.00310173697270476 0.00372208436724558
Stock impact report

Five Prime Therapeutics Licenses New Target to UCB Originating from its Proprietary Protein Discovery Platform

FIVE PRIME THERAPEUTICS (FPRX) 
Last five prime therapeutics earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.fiveprime.com/investor-relations
Company Research Source: Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, today announced UCB has elected to exclusively license an undisclosed drug target for inflammatory diseases. Five Prime identified the target using its discovery platform. “Our unique discovery platform is proving to be a drug target discovery engine, as evidenced by UCB’s decision to license a target we found through our customized in vivo screens and jointly developed cell based screens,” said Aron Knickerbocker, chief executive officer of Five Prime Therapeutics. “UCB is a leader in the research and development of biologics and brings tremendous expertise to this collaboration. We believe that our powerful platform is well suited to finding new pathways in complex diseases, and we’re pleased Show less Read more
Impact Snapshot
Event Time:
FPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for FPRX alerts
Opt-in for
FPRX alerts

from News Quantified
Opt-in for
FPRX alerts

from News Quantified